Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for NAII.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
March 31, 2026 20.59M
December 31, 2025 17.76M
September 30, 2025 18.91M
June 30, 2025 14.64M
March 31, 2025 11.65M
December 31, 2024 16.90M
September 30, 2024 17.62M
June 30, 2024 16.89M
March 31, 2024 11.22M
December 31, 2023 10.46M
September 30, 2023 9.751M
June 30, 2023 7.022M
March 31, 2023 7.611M
December 31, 2022 10.28M
September 30, 2022 14.82M
June 30, 2022 17.42M
March 31, 2022 16.74M
December 31, 2021 15.06M
September 30, 2021 20.24M
June 30, 2021 17.95M
March 31, 2021 16.88M
December 31, 2020 17.06M
September 30, 2020 19.17M
June 30, 2020 17.00M
March 31, 2020 12.38M
Date Value
December 31, 2019 14.23M
September 30, 2019 13.75M
June 30, 2019 15.96M
March 31, 2019 16.79M
December 31, 2018 13.54M
September 30, 2018 14.23M
June 30, 2018 16.12M
March 31, 2018 12.88M
December 31, 2017 14.40M
September 30, 2017 10.71M
June 30, 2017 8.41M
March 31, 2017 7.919M
December 31, 2016 9.838M
September 30, 2016 12.57M
June 30, 2016 13.22M
March 31, 2016 12.37M
December 31, 2015 7.574M
September 30, 2015 9.367M
June 30, 2015 9.895M
March 31, 2015 7.947M
December 31, 2014 4.702M
September 30, 2014 7.893M
June 30, 2014 6.835M
March 31, 2014 6.843M
December 31, 2013 5.639M

Accounts Receivable Definition

Represents change in working capital due to increase or decrease in receivables for the given period.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Cyanotech Corp. 2.23M
Mannatech, Inc. 0.137M
USANA Health Sciences, Inc. 3.337M
Nature's Sunshine Products, Inc. 13.86M
LifeVantage Corp. 2.99M